## HBAN: Huntington Bancshares Incorpora - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.3% in mid entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (3.8%) confirms momentum alignment. Strong momentum (+4.3% 5-day acceleration). Outperforming sector by 5.5%. Caution: overbought RSI (78).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($17.19)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Huntington Bancshares (HBAN) to Present at Goldman Sachs Financial Services Conference**
- Source: GuruFocus | 20251210T012133 | Somewhat-Bullish | Relevance: 99%
-  Huntington Bancshares (HBAN) will present at the 2025 Goldman Sachs Financial Services Conference on December 10, 2025. CEO Steve Steinour and CFO Zach Wasserman will provide strategic insights and a financial outlook. Presentation slides will be available on Huntington's investor relations website under Regulation FD disclosure.

**2. Is Huntington Stock A Buy Now?**
- Source: StocksToTrade | 20251210T212546 | Bullish | Relevance: 99%
-  Huntington Bancshares (HBAN) stock has seen a 3.35% increase due to investor optimism from quarterly earnings. The company is streamlining operations by downsizing Cadence Bank's workforce post-acquisition and has received a $100+ million equity infusion for expansion into aerospace and medical technology. Jefferies raised Huntington's price target to $20, maintaining a "Buy" rating, signaling confidence in its future growth despite ongoing scrutiny of the Cadence merger's shareholder benefits.

**3. Is Huntington Bancshares Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251211T090856 | Neutral | Relevance: 98%
-  Huntington Bancshares (HBAN) is a large-cap regional financial services company that has seen its stock fall 2.6% from its 52-week high, underperforming the Dow Jones Industrial Average over the past three months and year-to-date. Despite this, analysts maintain a "Moderate Buy" rating with a 13% upside to the mean price target. The company recently cut its prime rate, leading to a temporary stock increase.

**4. Cerity Partners LLC Buys 409,135 Shares of Huntington Bancshares Incorporated $HBAN**
- Source: MarketBeat | 20251210T093736 | Bullish | Relevance: 98%
-  Cerity Partners LLC significantly increased its stake in Huntington Bancshares Incorporated (NASDAQ:HBAN) by 69.6% in the second quarter, purchasing an additional 409,135 shares. This acquisition brings their total holdings to 997,131 shares valued at approximately $16.7 million. Other institutional investors also adjusted their positions, and analysts maintain a "Moderate Buy" rating for HBAN, with an average price target of $19.69.

**5. Huntington Bancshares Incorporated Decreases Its Prime Rate To 6.75 Percent**
- Source: Barchart.com | 20251210T220815 | Neutral | Relevance: 98%
-  Huntington Bancshares Incorporated announced a decrease in its prime rate from 7.00 percent to 6.75 percent, effective December 11, 2025. This follows a previous rate change on October 30, 2025, where the rate decreased from 7.25 percent to 7.00 percent. Huntington is a $223 billion asset regional bank holding company headquartered in Columbus, Ohio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Piper Sandler | $16 | $15 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Piper Sandler | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.10M) |
| Sells | 5 ($0.87M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.4%)
- Blackrock Inc.: 9.5% (-3.0%)
- State Street Corpora: 5.1% (-0.8%)
- Price (T.Rowe) Assoc: 4.3% (-2.2%)
- Boston Partners: 4.3% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.94 elevated, pricing in significant growth expectations. Forward P/E 11.6x stretched relative to 5% growth. Quality metrics strong (margin 30%). Balance sheet: strong liquidity (63.0x). Revenue growth strong at 36% YoY. Analyst sentiment positive (1 raises, avg +7%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.2B |
| Beta | 0.98 |
| 52W Range | $11.92 - $18.03 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.94 |
| Forward P/E | 11.6 |
| Current P/E | 12.2 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.0% to 7.3% (+4.3% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.8% confirms short-term momentum alignment. AM_20 at 9.6% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 78, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.31% (CS: 87) | Strong |
| RSI_14 | 77.9 | Overbought |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 1.096x | Above |
| vs SMA50 | 1.115x | Above |
| vs SMA200 | 1.120x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $17.91
- **Stop Loss:** $17.19 (4.0% risk)
- **Target:** $18.99 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1916
- **Position Value:** $34,315.56
- **Portfolio %:** 34.32%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.38 | $0.41 | +9.1% |
| 2025Q2 | $0.33 | $0.34 | +1.7% |
| 2025Q1 | $0.31 | $0.34 | +8.5% |
| 2024Q4 | $0.31 | $0.34 | +10.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*